Resources
-
Medical Metrics- Others
- Imaging
-
Introduction to FDA Guidance on the Development of SaMD (Chinese version)- White Paper
- SaMD
-
Micron’s ViewPoint 第20号(医疗器械软件(SaMD)的开发- FDA指南简介-)中文版- White Paper
- SaMD
- AI
-
FDA Guidance Clinical Trial Imaging Endpoint Process Standards 1 -Background for planning an imaging study-- Video
- Imaging
- Guidance
-
FDA Guidance Clinical Trial Imaging Endpoint Process Standards 2 -Micron’s experience-- Video
- Imaging
- Guidance
-
Imaging Biomarkers for the efficacy evaluation of regenerative medicine- Video
- Imaging
- Regenerative
-
Standardization of clinical trials imaging endpoints- Video
- Imaging
-
Solution for De-Identification Failure of DICOM Images- Video
- Imaging
- Products
-
Image Uploading and Reporting System:IRUMneo&i-Boarding- Video
- Imaging
-
Comparison of the CDE Guidance and the FDA Guidance for Antitumor Clinical Trials using Imaging Endpoints- Video
- Imaging
-
ATRaS Demonstration- Video
- Imaging
- Products
-
Computer-Aided Detection/Diagnosis (CAD) Using AI- Others
- SaMD
- AI
-
Regulatory Process for Medical Device Software in Japan- Others
- SaMD
- Guidance
-
Satety Evaluation of Anti-Amyloid-β Antibodies in Alzheimer’s Disease – ARIA (Chinese version)- White Paper
- Imaging
- CNS
- MRI
-
Satety Evaluation of Anti-Amyloid-β Antibodies in Alzheimer’s Disease – ARIA- White Paper
- Imaging
-
Micron’s ViewPoint 第19号(阿尔茨海默病中抗β淀粉样蛋白抗体的安全性评价~ARIA~)中文版- White Paper
- Imaging
- CNS
- MRI
-
The Utilization Situation of Imaging Endpoints – An Imaging Endpoint List –- White Paper
- Imaging
-
The Methodology of Centralized Image Interpretation and Roles of an Imaging CRO: Centralized Image Interpretation Variations- White Paper
- Imaging
-
The Methodology of Centralized Image Interpretation and Roles of an Imaging CRO: An Overview- White Paper
- Imaging
-
Chinese Materials- White Paper
-
The Development of Software as a Medical Device (SaMD) -Clarification of Clinical Significance-- White Paper
- SaMD
-
Publication Notice Clinical Trials for Medical Imaging Diagnostic Decision Support Systems – The Social Implementation of Medical Artificial Intelligence -- White Paper
- SaMD
-
Publication Notice Clinical Application of a Brain Image Analysis Program for Multiple Sclerosis Part 3: Clinical Significance of “Brain Volume Visualization” A Treatment Strategy for Long-Term Prognosis- White Paper
- Imaging
- CNS
- MRI
-
Publication Notice Clinical Application of a Brain Image Analysis Program for Multiple Sclerosis Part 2: The Usefulness in Multiple Sclerosis Treatment: Potential of Being a Part of a New Evaluation Scale- White Paper
- Imaging
- CNS
- MRI
-
Publication Notice Clinical Application of a Brain Image Analysis Program for Multiple Sclerosis Part 1: Multiple Sclerosis and Diagnostic Imaging- White Paper
- Imaging
- CNS
- MRI
-
Kobe Cardiovascular Core Laboratory – Introduction on the Service for Clinical Trials Using Intravascular Imaging Endpoints- White Paper
- Imaging
-
iRECIST Overview- White Paper
- Imaging
-
Clinical Evaluation of AI medical image diagnostic software: The Importance of the Reference Standards- White Paper
- SaMD
Please feel free to contact us
We provide comprehensive, end‑to‑end clinical development support, with imaging at its core.
With more than 20 years of experience, our team of imaging specialists in Japan and around the world tackles the complex challenges of imaging evaluation in pharmaceutical and medical device development. We deliver optimal, project‑specific solutions for each client.